Advertisement

Topics

Treating Crohn's with adalimumab may boost remission rates, study says

05:58 EDT 13 Jun 2019 | SmartBrief

Patients who were treated with adalimumab within two years of Crohn's disease diagnosis had a better chance of achieving remi -More

Original Article: Treating Crohn's with adalimumab may boost remission rates, study says

NEXT ARTICLE

More From BioPortfolio on "Treating Crohn's with adalimumab may boost remission rates, study says"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Crohn's Disease (CD)
Crohn’s disease (CD) is a long-term condition that causes inflammation of the lining of the digestive system.  Inflammation can affect any part of the digestive system, from the mouth to the back passage, but most commonly occurs in the last s...